We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+10)
Local Times (GMT+2)
Login
Session Groups
Session Types
Meet the Experts / Campfire Session
Posters
Session
Symposium
Featured Communication
Pre-Congress Course
Spotlight Session
Data Blitz Session
Special Format
Plenary
Networking
Break
Selected Colloquium
Sponsored Symposium
Rooms
Back
Posters
Poster Area
Tuesday, June 17, 01:25 PM – 01:55 PM
Poster Session 4: Childhood & Adolescent Disorders, ADHD, Dementia, Epilepsy, Pain, Variable
Chair:
Lianne Schmaal (Melbourne, Australia)
Role of the anterior insula and the endocannabinoid system in Autism neurodevelopmental disorder
Speaker:
Elena Martín García (Barcelona, Spain)
Therapeutic potential of low-dose opioids through brain region-specific neural activation for autism spectrum disorder
Speaker:
Rei Yokoyama (Hiroshima, Japan)
Developmental inhibition of Purkinje cells causes male-specific ASD-like phenotypes - vulnerable male cerebellum hypothesis
Speaker:
Satoshi Kamijo (Tokyo, Japan)
α6GABA
A
receptor-selective positive allosteric modulator as a potential therapy for autism: A preclinical study in Fmr1 KO mice
Speaker:
Yu-Hsuan Lee (Taipei, Taiwan)
Effects of low dose valproic acid on sleep disorders in autism spectrum disorder
Speaker:
Eiji Nakagawa (Tokyo, Japan)
Does prenatal exposure to low-dose di-2-ethylhexyl phthalate impair neurodevelopment in a Val66Met BDNF mouse model?
Speaker:
Alicia Bjorksten (Melbourne, Australia)
A Novel Diathesis-Stress Model of Commonly Comorbid Early Onset Psychiatric Disorders
Speaker:
Charlotte Caswell (Montreal, Canada)
Role of attention deficit hyperactivity disorder and major depressive disorder on executive dysfunction and appetite hormone dysregulation and proinflammatory cytokines among adolescents with death ideation
Speaker:
Jia Shyun Jeng (Taipei, Taiwan)
Cannabidiol mitigates cognitive deficits in a mouse model of Alzheimer’s disease
Speaker:
Yi-Chia Chen (Tainan, Taiwan)
RX 821002, an alpha2 adrenoceptor antagonist, enhances acetylcholine efflux in the nucleus accumbens of freely moving rats following intra-accumbal and systemic administration
Speaker:
Kazuki Arai (Chiba, Japan)
Protective effects of Shati/Nat8l on Aβ neurotoxicity in the cultured Neuro-2a cells
Speaker:
Miho Takakuwa (Toyama City, Japan)
Decreased brain pH correlated with progression of Alzheimer’s disease neuropathology: a systematic review and meta-analyses of postmortem studies
Speaker:
Hideo Hagihara (Toyoake, Japan)
Cognitive flexibility as a possible index of age-related cognitive decline
Speaker:
Masaki Kakeyama (Tokorozawa, Japan)
Genome-wide association study of frailty in middle-aged adults: insights from
ZNF552
rs2288538 variant
Speaker:
Tung-Hsia Liu (Miaoli County, Taiwan)
Glycosylation modifications correlating with plasma CCL11 elevation in patients with moderate dementia
Speaker:
Yu-Li Liu (Miaoli County, Taiwan)
Effects of 24-month supplementation of EPA and dha on hippocampal spontaneous neuroactivity in mild cognitive impairment and dementia: a resting-state fMRI study
Speaker:
Chen-Chia Lan (Taichung, Taiwan)
Theoretical drug selection for BPSD
Speaker:
Shuji Iritani (Toyoake, Japan)
Unveiling the Cognitive Enhancing Effects of RS-D7, a Novel NMDAR Modulator, on Hippocampus-Dependent Learning and Memory in Mice
Speaker:
Hsin-Ching Chien (Taipei, Taiwan)
Toxicity and metabolism of structurally similar fentanyl analogs with the integrated
approach using
in vitro
experiments and
in silico
predictions
Speaker:
Ryo Hiramasu (Gifu, Japan)
The development of AUFEI: culture-centered executive function measurement tools for indonesian children and adolescents
Speaker:
Suzy Yusna Dewi (Jakarta, Indonesia)
Changes in decision making behavior between pregnancy and postpartum
Speaker:
M. Mercedes Perez-Rodriguez (New York, United States)
Exploring the Association Between Prenatal SARS-CoV-2 Infection, Placental Immune and Inflammatory Gene Expression and Postpartum Depression with a Validation Analysis
Speaker:
M. Mercedes Perez-Rodriguez (New York, United States)
The role of neutrophil myeloperoxidase and the neuronal injury marker neurofilament light chain in COVID-19 infected patients
Speaker:
Shu Chih Liu (Miaoli, Taiwan)
Regulatory mechanism of astrocytic glutamine synthetase expression in epileptic brain via Hippo-YAP pathway
Speaker:
Yusuke Nasu (Niigata, Japan)
The role of ANT in modulating hippocampal oscillations in animal models of epilepsy
Speaker:
Yu-Chieh Huang (Tainan, Taiwan)
Are Persistent Somatic Symptoms a Trans-Diagnostic Concept? A cluster analysis
Speaker:
Wei-Lieh Huang (Douliu, Taiwan)
The relieving effect of activating the pleasure center VTA on chronic stress-induced hyperalgesia
Speaker:
An-Chi Hsu (Tainan, Taiwan)
Effect of cannabinoid CB2 agonist on cold hypersensitivity in mice with post-traumatic trigeminal neuropathy
Speaker:
Simeng Ma (Hiroshima, Japan)
Enhancement of
in vivo
dopamine efflux in the rat nucleus accumbens by orexin OX
2
receptor blockade is reduced in two chronic pain models
Speaker:
Tadashi Saigusa (Matsudo, Japan)
Glutamate, glutamine, and GABA levels in adults with autism spectrum disorder: a 7T MRS study
Speaker:
Manabu Kubota (Chiba, Japan)
Exploring the dynamics of L1 retrotransposition in natural aging: Insights from the mouse model
Speaker:
Chu Guo (Kumamoto, Japan)
Neuropsychiatric symptoms as predictors for cognitive impairment and revert factors for normal cognition: a one-year prospective cohort study
Speaker:
Daochompu Nakawiro (Bangkok, Thailand)
DNMT1 complex disorders: neurodegeneration from a specific DNA methylation defect. The mutation knock in mouse model present similar to clinical form of HSAN1E
Speaker:
Kaori Hojo (Hyogo Prefect, Japan)